Back to DE D. E. Shaw & Co., Inc.

SUPNSUPN
29 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in SUPERNUS PHARMACEUTICALS

D. E. Shaw & Co., Inc. holds 622,450 shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $32.2M as of 2026-Q1. The position was decreased (-12.1% shares). SUPN represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$32.2M

Current Shares

622,450

Total Value Change

+$30.4M

Total Shares Change

+569,548

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
622,450
-12.1%
$32.2M0.0%$54.56
0
2025-Q4
Decreased
707,982
-27.7%
$35.2M0.0%$49.89
0
2025-Q3
Increased
979,604
+63.6%
$46.8M0.0%$47.60
43
2025-Q2
Increased
598,621
+27.9%
$18.9M0.0%$31.16
35
2025-Q1
Decreased
467,881
-14.3%
$15.3M0.0%$32.29
0
2024-Q4
Increased
545,658
+33.5%
$19.7M0.0%$36.91
36
2024-Q3
Increased
408,788
+40.6%
$12.7M0.0%$30.75
37
2024-Q2
Increased
290,797
+123.1%
$7.8M0.0%$26.75
44
2024-Q1
Increased
130,366
+0.9%
$4.4M0.0%$34.11
27
2023-Q4
Increased
129,153
+416.1%
$3.7M0.0%$28.94
43
2023-Q3
Increased
25,023
+2.1%
$689,8840.0%$27.57
25
2023-Q2
Decreased
24,500
-16.3%
$736,4700.0%$29.91
0
2023-Q1
Decreased
29,276
-0.3%
$1.1M0.0%$36.27
0
2022-Q4
Increased
29,353
+7.9%
$1M0.0%$35.67
27
2022-Q3
Increased
27,200
+68.9%
$921,0000.0%$33.28
37
2022-Q2
Increased
16,100
+108.0%
$466,0000.0%$28.50
39
2022-Q1
New
7,740
-
$250,0000.0%$32.40
32
2021-Q3
Exited
0
-100.0%
$00.0%$26.85
0
2021-Q2
Decreased
9,923
-32.8%
$306,0000.0%$31.63
0
2021-Q1
Decreased
14,764
-31.0%
$387,0000.0%$26.17
0
2020-Q4
Decreased
21,407
-84.5%
$539,0000.0%$25.08
0
2020-Q3
Decreased
138,524
-40.2%
$2.9M0.0%$20.86
0
2020-Q2
Increased
231,775
+1.4%
$5.5M0.0%$23.27
27
2020-Q1
Increased
228,478
+43.8%
$4.1M0.0%$17.16
36
2019-Q4
Increased
158,848
+1112.6%
$3.8M0.0%$23.35
43
2019-Q3
New
13,100
-
$360,0000.0%$27.47
33
2019-Q2
Exited
0
-100.0%
$00.0%$33.09
0
2019-Q1
Decreased
27,535
-48.0%
$965,0000.0%$35.04
0
2018-Q4
New
52,902
-
$1.8M0.0%$32.36
36

Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used